Commonly prescribed oral anti-obesity medication and alternative anorectics

Julien S. Baker; Bruce Davies; Michael R. Graham

doi:10.1057/978-1-137-53535-1_10

Commonly prescribed oral anti-obesity medication and alternative anorectics

Julien S. Baker
, Bruce Davies
, Michael R. Graham

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Citations (Scopus)

Abstract

Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the ``golden bullet''. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the ``fen-phen'' prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.

Original language	English
Title of host publication	Chemically Modified Bodies
Subtitle of host publication	The Use of Diverse Substances for Appearance Enhancement
Editors	Matthew Hall, Sarah Grogan, Brendan Gough
Place of Publication	London
Publisher	Palgrave Macmillan US
Chapter	10
Pages	173-199
Number of pages	27
ISBN (Electronic)	978-1-137-53535-1
ISBN (Print)	978-1-137-53534-4
DOIs	https://doi.org/10.1057/978-1-137-53535-1_10
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1057/978-1-137-53535-1_10

Cite this

@inbook{8b0493522049440cb732ccbbdeaec0f2,

title = "Commonly prescribed oral anti-obesity medication and alternative anorectics",

abstract = "Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the ``golden bullet''. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the ``fen-phen'' prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.",

author = "Baker, \{Julien S.\} and Bruce Davies and Graham, \{Michael R.\}",

year = "2016",

doi = "10.1057/978-1-137-53535-1\_10",

language = "English",

isbn = "978-1-137-53534-4",

pages = "173--199",

editor = "Matthew Hall and Sarah Grogan and Brendan Gough",

booktitle = "Chemically Modified Bodies",

publisher = "Palgrave Macmillan US",

address = "United States",

}

Commonly prescribed oral anti-obesity medication and alternative anorectics. / Baker, Julien S.; Davies, Bruce; Graham, Michael R.
Chemically Modified Bodies: The Use of Diverse Substances for Appearance Enhancement. ed. / Matthew Hall; Sarah Grogan; Brendan Gough. London: Palgrave Macmillan US, 2016. p. 173-199.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - Commonly prescribed oral anti-obesity medication and alternative anorectics

AU - Baker, Julien S.

AU - Davies, Bruce

AU - Graham, Michael R.

PY - 2016

Y1 - 2016

N2 - Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the ``golden bullet''. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the ``fen-phen'' prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.

AB - Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the ``golden bullet''. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the ``fen-phen'' prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.

U2 - 10.1057/978-1-137-53535-1_10

DO - 10.1057/978-1-137-53535-1_10

M3 - Chapter

SN - 978-1-137-53534-4

SP - 173

EP - 199

BT - Chemically Modified Bodies

A2 - Hall, Matthew

A2 - Grogan, Sarah

A2 - Gough, Brendan

PB - Palgrave Macmillan US

CY - London

ER -

Commonly prescribed oral anti-obesity medication and alternative anorectics

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this